期刊文献+

α干扰素促进急性髓性白血病来源的树突状细胞的成熟分化 被引量:1

IFN-alpha promotes the full maturation of dendritic cells derived from acute myeloid leukemia cells in vitro
下载PDF
导出
摘要 目的:研究α干扰素(interferon alpha,IFN-α)对不同亚型的急性髓性白血病(acute myeloid leukemia,AML)细胞来源的树突状细胞(dendritic cell,DC)免疫表型及功能的影响。方法:5例初发AML患者(其中M2 1例、M4 2例、M5 2例)的外周血单个核细胞,在含GM-CSF、IL-4、TNF-α的无血清培养液中培养11 d,其后加入IFN-α-2a(1 000 U/ml)继续培养3 d,获得DC(IFN-AML-DC),光镜下观察细胞形态,流式细胞仪测定细胞免疫表型,同种异体混和淋巴细胞反应检测DC的免疫功能。结果:所有患者白血病细胞培养14 d后均转化为IFN-AML-DC,与正常人外周血单核细胞由GM-CSF+IL-4+TNF-α培养获得的DC(monocyte-derived DC,MoDC)及AML细胞由GM-CSF+IL-4+TNF-α培养获得的DC(AML-DC)相比,IFN-AML-DC具有典型成熟形态的细胞明显增多,表达CD83+细胞的比例显著增加,HLA-DR、CD86分子的表达水平增高,对同种异体T淋巴细胞的激活能力明显高于MoDC及AML-DC。结论:IFN-α能够促进AML-DC的体外成熟,形成更强的免疫激活能力,为AML的免疫治疗提供更有力的手段。 Objective: To explore the influences of interferon alpha (IFN-α) on the phenotype and function of dendri tic cell (DC) derived from acute myeloid leukemia (AML) cells in vitro. Methods: Peripheral blood mononuclear cells (PBMCs) from 5 AML patients( 1 with M2, 2 with M4, and 2 with MS) were incubated concurrently with granulocytemacrophage colony-stimulating factor ( GM-CSF), interleukin4 ( IL4 ), and tumor necrosis factor-α (TNF-α) for 11 days and then IFN-α 2 (1 000 U/ml) was added for another 3 days' culture to acquire IFN-AML-DC. The cell morphology was observed under light microscope. Immunophenotypic features and function of IFN-AML-DC were evaluated by flow cytometry and allogeneic mixed lymphocyte reaction (allo-MLR) assay, respectively. Results: DCs were generated from blasts of all patients when cultured with IFN-α/GM-CSF/IL4/TNF-α. Compared with DCs derived from normal PBMCs ( GM-CSF + IL4 + TNF-α) and AML cells ( GM-CSF + IL4 + TNF-α), more IFN-AML-DCs exhibited morphological and immunophenotypic features of mature DCs, including higher expression level of CD83, HLA-DR, and CD86 and more potent Allo-MLR stimulatory capacity. Conclusion: IFN-α can promote the maturation of AML-DC in vitro, leading to more potent immunoactivating ability, which provides a more effective way for immunotherapy of AML.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2007年第6期557-561,共5页 Chinese Journal of Cancer Biotherapy
关键词 Α干扰素 急性髓性白血病 树突状细胞 免疫治疗 interferon alpha acute myeloid leukemia dendritic cell immunotherapy
  • 相关文献

参考文献19

  • 1Mohty M,Vialle-Castellano A,Nunes JA,et al.IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities[J].J Immunol,2003,171(7):3385-3393.
  • 2Dauer M,Schad K,Junkmann J,et al.IFN-alpha promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4[J].J Leukoc Biol,2006,80(2):278-286.
  • 3Paquette RL,Hsu NC,Kiertscher SM,et al.Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells[J].J Leukoc Biol,1998,64(3):358-367.
  • 4Radvanyi LG,Banerjee A,Weir M,et al.Low levels of interferon-alpha induce CD86(B7.2)expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells[J].Scand J Immunol,1999,50(5):499-509.
  • 5Gabriele L,Borghi P,Rozera C,et al.IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment[J].Blood,2004,103(3):980-987.
  • 6Paquette RL,Hsu N,Said J,et al.Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo[J].Leukemia,2002,16(8):1484-1489.
  • 7Wang C,Al-Omar HM,Radvanyi L,et al.Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha[J].Exp Hematol,1999,27(7):1176-1184.
  • 8Chen X,Regn S,Raffegerst S,et al.Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia[J].Br J Haematol,2000,111(2):596-607.
  • 9Lee JJ,Choi BH,Nam JH,et al.The generation of leukemic dendritic cells from acute myeloid leukemia cells is potentiated by the addition of CD40L at the terminal maturation stage[J].J Clin Apher,2004,19(3):130-136.
  • 10Kufner S,Fleischer RP,Kroell T,et al.Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes[J].Cancer Immunol Immunother,2005,54(10):953-970.

二级参考文献3

共引文献101

同被引文献32

  • 1陈虎,楼晓,江岷,胡亮钉,俞志勇,徐晨,李渤涛,宁红梅,李欲航,冯凯,刘广贤.树突状细胞介导的抗白血病效应的临床研究[J].中国实验血液学杂志,2005,13(3):412-416. 被引量:9
  • 2Hamadani M, Awan FT, Copelan EA. Hematopoietic stem cell transplantation in adults with acute myeloid leukemia [ J ]. Biol Blood Marrow Transplant, 2008, 14(5) : 556-567.
  • 3Blum W, Mareucci G. New approaches in acute myeloid leukemia [J].Best Pract Res Clin Haematol, 2008, 21 ( 1 ) : 29-41.
  • 4Van de Velde AL, Berneman ZN, Van Tendeloo VF. Immunotherapy of hematological malignancies using dendritic cells [J]. Bull Cancer, 2008, 95 (3) : 320-326.
  • 5Buzzai M, Licht JD. New molecular concepts and targets in acute myeloid leukemia [J].Curt Opin Hematol, 2008, 15 (2) : 82-87.
  • 6Osman Y, Takahashi M, Zheng Z, et al. Dendritic cells stimulate the expansion of PML-RAR alpha specific cytotoxic T-lymphocytes: its applicability for antileukemia immunotherapy[J].J Exp Clin Cancer Res, 1999, 18(4) : 485-492.
  • 7Maeda M, Otsuka T, Kimura N, et al. Induction of MTG8specific cytotoxic T-cell lines: MTG8 is probably a tumour antigen that is recognized by cytotoxic T cells in AME1-MTG8-fused genepositive acute myelogenous leukaemia[ J]. Br J Haematol, 2000, 111(2) : 570-579.
  • 8Guinn BA, Bland EA, Lodi U, et al. Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia [J].Biochem Biophys Res Commun, 2005, 335(4): 1293- 1304.
  • 9Delluc S, Tourneur L, Michallet AS, et al. Autologous peptides eluted from acute myeloid leukemia cells can be used to generate specific antileukemic CD4 helper and CD8 cytotoxic T lymphocyte responses in vitro [ J ]. Haematologica, 2005, 90 ( 8 ) : 1050-1062.
  • 10Delluc S, Tournenr L, Fradelizi D, et al. DC-based vaccine loaded with acid-eluted peptides in acute myeloid leukemia: the importance of choosing the best elution method[ J]. Cancer Immunol Immunother, 2007, 56( 1 ) : 1-12.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部